Landmark Study Shows Ultromics’ EchoGo® Amyloidosis Significantly Improves Detection of Cardiac Amyloidosis with Echocardiography
Publisher
Ultromics
Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.
Canonical metadata stays public, while full text remains on the original site.